Rebecca Byam, Chief Financial Officer at HCW Biologics Inc. (HCWB), bought 30,000 shares at $2.58 ($78K) on 2022-09-13, disclosed to the SEC on 2022-09-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.65 | 15,000 | $40K | 50.7% |
| 2 | $2.58 | 15,000 | $39K | 49.3% |
| Total | $2.62 avg | 30,000 | $78K | 100% |
| Filing → |
| HCWB | BUY | 2023-09-15 | $11K | — | Filing → |
| HCWB | BUY | 2023-09-13 | $21K | — | Filing → |
| HCWB | BUY | 2023-09-08 | $20K | — | Filing → |